RAC 4.00% $1.44 race oncology ltd

Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells, page-131

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,869 Posts.
    lightbulb Created with Sketch. 1858
    Re being "helpful" - I expect you're right. Hope so.

    RAC probably has the most interactive input from shareholders of any biotech on the ASX, being filtered through you, I guess you would say. Anything else like it anywhere?

    Did this actually help or hinder DCB I wonder. That's an interesting thought - to look at that situation from his perspective. Feels like a "hospital pass" pondering it now. I wonder how he feels. I wonder if he's still a shareholder.

    So RAC as we know it, now with you as the largest shareholder, has a shareholder participation model unlike any other ... which combined with the link to Merchant ... Q3 T20 data not far off.

    And now you're the consultant representative of the Exec.

    I'm glad you're back and hope you can help steer the ship into better seas.

    Last edited by EWexplorer: 24/09/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.44
Change
-0.060(4.00%)
Mkt cap ! $245.4M
Open High Low Value Volume
$1.50 $1.50 $1.44 $57.11K 38.73K

Buyers (Bids)

No. Vol. Price($)
2 2499 $1.44
 

Sellers (Offers)

Price($) Vol. No.
$1.46 247 1
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.